@FierceMedDev: Post-pharma Abbott soars on Dx, struggles with devices. Article | Follow @FierceMedDev
@MarkHFierce: Rather than sell its healthcare division outright, Panasonic is now looking for an investor. More | Follow @MarkHFierce
@DamianFierce: The first quarter wasn't all that kind to St. Jude, but the company still believes it can chart a big 2013. Story | Follow @DamianFierce
> Covidien ($COV) is launching two new surgical access devices designed to protect wounds from contamination in minimally invasive surgeries. More
> Swedish surgical device giant Getinge posted a drop in profit last quarter but is forecasting a rise on the year thanks to emerging markets growth. Article
> Quest Diagnostics ($DGX) plans to buy the lab-related clinical outreach service operations of Dignity Health, a California-based hospital system. News
> In the Myriad Genetics ($MYGN) case, the Supreme Court may end up allowing patents for synthetically created genes but not isolated ones, according to an intellectual property attorney. Story
> Medical device startups founded by physicians tend to produce more worthwhile patents, according to a new study. Release
> The latest advance in WiFi technology could be a boon for medical device connectivity. Report
Biotech News
@FierceBiotech: Alkernes announces positive PhII results for antiepressant ALKS 5461. More | Follow @FierceBiotech
@RyanMFierce: Top 10 Biotech IT Investments in the past year. Special Report | Follow @RyanMFierce
> Thiel's Breakout Labs awards new grants to biotech startups. More
> Biogen Idec, big biotechs trounce pharma players on multiple fronts this decade. Story
> Eli Lilly rolls the dice on combo approach against Alzheimer's disease. Article
Pharma News
@FiercePharma: U.S. lawmakers introduce "dual-eligibles" bill to hike rebates on drugs for low-income Medicare patients. More | Follow @FiercePharma
@EricPFierce: FDA decision on OxyContin tough for some drugmakers but a boost for others. Article | Follow @EricPFierce
> Amgen to pay $25M to wrap up Aranesp kickbacks case. Article
> Dual-eligibles bill sets up another pharma fight over Medicare rebates. More
> Vivus revs up new Qsymia sales plan after FDA removes a roadblock. Story
Biomarkers News
> Scientists use fMRI, neurological pattern to diagnose pain. Item
> Presence of certain bacteria could indicate dangerous infant disorder. More
> Biomarker could help guide treatment for aggressive breast cancer. Report
> Discovery: Thousands of genes mark schizophrenia risk. Article
> Biomarker for liver problems also predicts lung cancer likelihood. Story
Drug Delivery News
@MichaelGFierce: UCLA team uses diamonds to tackle tricky form of breast cancer. Report | Follow @MichaelGFierce
> Inner-ear drug delivery draws $50.6M for Auris Medical. Story
> Delivery nanotech gives RNAi potential a boost. More
> Novaliq pulls in $18.1M for ocular delivery tech. News
> Self-propelled 'microrockets' carry drugs in active delivery approach. Article
> BIND Therapeutics completes PhI trial of first Accurin cancer drug. Item